Buying the fear? Check out top stock ideas of best performing PMS funds of May
PMS
fund managers have made sizable bets on stocks like
Precision Camshafts
,
Hitachi Energy India
, and
Nuvama Wealth Management
as geopolitical fears create entry points in quality names.
'Any correction coming would be an opportunity,' said Vikas Khemani of Carnelian Asset Management. 'India's earnings growth this year will be very robust, thanks to RBI easing, low inflation, and credit growth. I don't see a major risk, though the short term is hard to call.'
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Live Comfortably: 60 m² Prefab Bungalow for Seniors in Sidi Bel Abbes
Pre Fabricated Homes | Search Ads
Search Now
Undo
Leading the pack is NAFA Asset Managers' Clean Tech Portfolio, which returned a stellar 16.01% in May, the highest among PMS peers. The fund is riding hard on industrial and energy transition plays — with Precision Camshafts (18.37%), Hitachi Energy India (18.03%), and Linde India (11.82%) commanding hefty allocations. This portfolio is essentially a powertrain of cleantech conviction, according to data sourced from PMS Bazaar.
Negen Capital's Special Situations & Technology Fund, up 15.35%, isn't far behind. Its top holdings include Camlin Fine Sciences, Nuvama Wealth, and HEG Ltd, reflecting a tilt toward platform plays and special situation beneficiaries. Interestingly, Nuvama Wealth Management — a capital markets business — features in three top-performing PMS portfolios this month.
'We have a significant allocation to the capital markets story — AMCs, brokerages, exchanges,' said Siddharth Vora of PL Asset Management. 'It's a structural story, but we are not structural participants. We'll stay as long as the quantitative triggers remain.'
Live Events
One of the month's more repeated names is Interarch Building Products, showing up in four portfolios — including Accelt, Bonanza, Waya, and Anand Rathi. It's a quiet favourite among PMS managers riding the infra and pre-engineered buildings theme.
Among small-cap plays, Nine Rivers Capital's Aurum Small Cap Opportunities delivered a solid 14.4%, thanks to high-conviction allocations to Intellect Design Arena (9.6%), Astra Microwave, and CCL Products — the latter also held by Ambit Investment's Emerging Giants portfolio.
Another PMS manager with twin strategies in the top 10 — Samvitti Capital — is doubling down on mid-cap manufacturers and pharma exporters, including Kaynes Technology, Force Motors, Strides Pharma, and Gokaldas Exports, all of which appear in both its Aggressive Growth and Active Alpha portfolios.
Blue Jet Healthcare, a relatively new pharma listing, has found favour with both Accelt and Waya, while Camlin Fine Sciences, TD Power Systems, and Shankara Building Products show up in PMS strategies with more than 13% monthly returns.
'We expect markets to pause after the ~10% Nifty rally,' said Seshadri Sen of
Emkay Global
. 'Valuations are stretched, and if Middle East tensions escalate, a sell-off is possible. But we remain positive on discretionary, tech, and materials for the medium term.'
Despite the nerves, fund managers remain anchored in India's structural story — and they're placing their bets accordingly. From precision auto parts and building solutions to electronics, pharma, and financial services, this month's PMS portfolios offer a snapshot of what smart money believes will ride out the global storm.
Morgan Stanley noted in its recent India strategy that this is likely to be a 'stock pickers' market,' adding: 'We are capitalization agnostic.'
With that in mind, for investors looking to buy the fear, these stocks might just be your roadmap.
Also Read |
Rs 1 lakh gold, $78 oil, 1,300 point Sensex crash: Israel's Friday the 13th bombshell
(
Disclaimer
: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Print
an hour ago
- The Print
US promoting terrorism & dictatorship in the world—RSS mouthpiece days after Trump's 50% tariff bomb
'The world is in turmoil. All the promises of 'free' and 'democratic' liberal world order are proving to be elusive. The unruly world order monopolised by the United States and based on military might and economic exploitation is crumbling down,' the editorial says. 'Trade wars and tariffs are new tools of interference and undermining sovereignty,' the editorial said in the backdrop of the Trump administration raising tariffs on India to 50 percent. New Delhi: Under the façade of being a messiah of freedom and democracy, the United States is promoting terrorism and dictatorship in the world, Rashtriya Swayamsevak Sangh (RSS) mouthpiece Organiser has said in an editorial. US President Donald Trump on 6 August imposed an additional 25 percent tariff on India as a penalty for New Delhi's continued purchase of Russian oil. The duties are additional to the 25 percent tariff rate announced earlier by Trump. After the end of the world war, the editorial argued, 'it was assumed that the liberal world order had triumphed forever, leading to the spread of democracy, stability and peace across the world.' However, the situation today is 'drastically different from our assumptions', it says. The American unipolar world is in decline and the international institutions like the United Nations and the World Trade Organisation proving to be irrelevant and inefficient, it argues. 'We are witnessing trade wars, unnecessary tariffs, sanctions, and regime change operations. The United States, self-proclaimed messiah of freedom and democracy, is promoting terrorism and dictatorship,' it says. 'China is emerging as a major challenger to the existing system,' it said while underlining the country's 'debt trap' and lack of 'credible' stable institutions. 'Russia-Ukraine War, Israel-Hamas War and Israel-Iran conflicts are the symptoms of this crumbling international order—the clear sign of this crumbling world order—which was never orderly.' The RSS has been silent over the Trump administration's tariffs on India so far, even as its economic wing, the Swadeshi Jagran Manch, said that no country could 'direct' trade rules to another country in a multipolar world. It also appealed to people to adopt 'Swadeshi' products, urging them to boycott goods from US-based companies like Amazon, Walmart and Flipkart (in which Walmart has a majority stake). There is a concerted attempt by 'neo-colonisers' and their domestic agents with vested interests to suppress the cultural resurgence witnessed by India in the last few decades, the Organiser said in the editorial. 'Actions like Surgical Strikes, Operation Sindoor, and continuous assertion to ensure strategic autonomy through prudent foreign policy options are a symbol of the same national consciousness,' it said. 'The forces in favour of the status quo, driven by vested interests, continue to bully the world based on economic and military might. The new assertive Bharat is a bête noire for them. They are using all the neo-colonial machinations to suppress this instinct.' For short-term political interests, some players within Bharat are acting as agents of neo-colonisers, it stated. 'All proposed globalisations—whether American market globalisation, Islamic religious globalisation or ideology-driven Communist globalisation—are nothing but the forms of colonisation imposing a one-size-fits-all approach across the world,' it further said. In order to counter the challenges, it said, India 'will have to face the competition and conflicts based on the current parameters for which we need to be economically prosperous, technologically advanced and militarily self-sufficient'. It also draws a parallel between communism and capitalism, arguing that while the independence movement in India was based on the ideals of Swadharma, Swadeshi and Swaraj, 'unfortunately, the elite of Independent Bharat lost their resilience and succumbed to the binary of capitalism and communism'. (Edited by Ajeet Tiwari) Also Read: No option but to be powerful in face of evil forces at our borders—RSS chief Mohan Bhagwat in Organiser
Economic Times
4 hours ago
- Economic Times
PMS Tracker: Top 15 funds advance up to 14% in July; Maxiom, Kotak among biggest losers
Bottom performers: Maxiom, Kotak, Trivantage lead declines Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel At least 15 PMS funds across thematic, smallcap, and multicap strategies delivered gains in July 2025, with InCred Asset Management's Focused Healthcare Portfolio emerging as the top performer, posting a 14.29% monthly return, according to data from PMS Healthcare Portfolio followed with an 11.96% gain, while Valcreate Investment Managers' Lifesciences and Specialty Opportunities strategy rose 8.48% during the month. Green Portfolio's MNC Advantage added 6.89%, and Valcreate's IME Digital Disruption gained 6.34% in notable performers included Wallfort PMS and Advisory Services' Diversified Fund, which gained 4.88% in July 2025, Maximal Capital's Income Fund, up 4.55%, and Ambit Investment Advisors' Micro Marvels Portfolio, which rose 4.27%. Emkay Investment Managers' Pearls strategy climbed 4.20%, and Qode Advisors' Future Horizon added 2.91% during the multicap and flexicap strategies, ithought Financial's VRDDHI and Shade Capital's Value Fund each gained 2.87%, Valcreate's Growing India strategy rose 2.84%, Wryght Research's Factor Fund advanced 2.69%, White Whale Partners' North Star Portfolio was up 2.64%, and Brightseeds Advisors' Xylem Maverick Strategy closed the month 2.55% the losing side, Maxiom Asset Management's PMS – EMERALD strategy fell 9.54% in July, the steepest decline among tracked portfolios. Kotak Mahindra AMC's Fintech strategy dropped 9.19% during the month, while Trivantage Capital's Small and Midcap Financials slid 7.41%.Moat Financial Services' UpperCrust Wealth Fund declined 7.09%, ASK Investment Managers' Financial Opportunities Portfolio lost 7.06%, and Shree Rama Managers' Vriddhi Plan fell 6.75%. ASK's Emerging Opportunities Portfolio was down 6.73%, and Capitalmind's Adaptive Momentum dropped 6.31%.Other laggards included Tulsian PMS, which fell 6.19%, Right Horizons' Alphabots Midcap 29, down 6.09%, Bonanza Portfolio's Growth, which dropped 5.98%, Aditya Birla Sun Life AMC 's India Special Opportunities Portfolio, lower by 5.95%, Wallfort PMS's Focus Fund, which slipped 5.85%, Atlas Integrated Finance's Debt Equity Hybrid PMS Fund, down 5.82%, Bonanza Portfolio's Edge and Value strategies, which lost 5.78% and 5.76% respectively, Alchemy Capital's Smart Alpha 250, lower by 5.67%, Marcellus Investment Managers' Consistent Compounders, which declined 5.61%, Trivantage Capital's Edge Portfolio, down 5.46%, and 2Point2 Capital's Long Term Value Fund, which ended the month 5.40% July saw strong gains in healthcare-focused and select thematic strategies, while several multicap, sectoral, and small-and-midcap portfolios faced steep losses, underscoring continued divergence in PMS performance.(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of the Economic Times)
Time of India
5 hours ago
- Time of India
PMS Tracker: Top 15 funds advance up to 14% in July; Maxiom, Kotak among biggest losers
At least 15 PMS funds across thematic, smallcap, and multicap strategies delivered gains in July 2025, with InCred Asset Management's Focused Healthcare Portfolio emerging as the top performer, posting a 14.29% monthly return, according to data from PMS Bazaar. InCred's Healthcare Portfolio followed with an 11.96% gain, while Valcreate Investment Managers' Lifesciences and Specialty Opportunities strategy rose 8.48% during the month. Green Portfolio's MNC Advantage added 6.89%, and Valcreate's IME Digital Disruption gained 6.34% in July. Finance Value and Valuation Masterclass - Batch 4 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals Batch 2 By Ansh Mehra View Program Finance Value and Valuation Masterclass - Batch 3 By CA Himanshu Jain View Program Artificial Intelligence AI For Business Professionals By Vaibhav Sisinity View Program Finance Value and Valuation Masterclass - Batch 2 By CA Himanshu Jain View Program Finance Value and Valuation Masterclass Batch-1 By CA Himanshu Jain View Program Other notable performers included Wallfort PMS and Advisory Services' Diversified Fund, which gained 4.88% in July 2025, Maximal Capital's Income Fund, up 4.55%, and Ambit Investment Advisors' Micro Marvels Portfolio, which rose 4.27%. Emkay Investment Managers' Pearls strategy climbed 4.20%, and Qode Advisors' Future Horizon added 2.91% during the month. Among multicap and flexicap strategies, ithought Financial's VRDDHI and Shade Capital's Value Fund each gained 2.87%, Valcreate's Growing India strategy rose 2.84%, Wryght Research's Factor Fund advanced 2.69%, White Whale Partners' North Star Portfolio was up 2.64%, and Brightseeds Advisors' Xylem Maverick Strategy closed the month 2.55% higher. Bottom performers: Maxiom, Kotak, Trivantage lead declines On the losing side, Maxiom Asset Management's PMS – EMERALD strategy fell 9.54% in July, the steepest decline among tracked portfolios. Kotak Mahindra AMC's Fintech strategy dropped 9.19% during the month, while Trivantage Capital's Small and Midcap Financials slid 7.41%. Live Events Moat Financial Services' UpperCrust Wealth Fund declined 7.09%, ASK Investment Managers' Financial Opportunities Portfolio lost 7.06%, and Shree Rama Managers' Vriddhi Plan fell 6.75%. ASK's Emerging Opportunities Portfolio was down 6.73%, and Capitalmind's Adaptive Momentum dropped 6.31%. Other laggards included Tulsian PMS, which fell 6.19%, Right Horizons' Alphabots Midcap 29, down 6.09%, Bonanza Portfolio's Growth, which dropped 5.98%, Aditya Birla Sun Life AMC 's India Special Opportunities Portfolio, lower by 5.95%, Wallfort PMS's Focus Fund, which slipped 5.85%, Atlas Integrated Finance's Debt Equity Hybrid PMS Fund, down 5.82%, Bonanza Portfolio's Edge and Value strategies, which lost 5.78% and 5.76% respectively, Alchemy Capital's Smart Alpha 250, lower by 5.67%, Marcellus Investment Managers' Consistent Compounders, which declined 5.61%, Trivantage Capital's Edge Portfolio, down 5.46%, and 2Point2 Capital's Long Term Value Fund, which ended the month 5.40% lower. Overall, July saw strong gains in healthcare-focused and select thematic strategies, while several multicap, sectoral, and small-and-midcap portfolios faced steep losses, underscoring continued divergence in PMS performance. Also read | Sebi looks to further ease regulations for foreign investors
